Visit COVID-19 resources

[Skip to Content]

‘Statins in retinal disease’ – (‘Statins in retinal disease’, Published online: 2018-03-20; | doi:10.1038/s41433-018-0066-7)

Mar 20
2018

‘Statins in retinal disease’ ‘Statins in retinal disease’, Published online: 20 March 2018; doi:10.1038/s41433-018-0066-7 ‘Statins in retinal disease’

  • 20 March 2018

Torpedo maculopathy: disease spectrum and associated choroidal neovascularisation in a paediatric population – (Torpedo maculopathy: disease spectrum and associated choroidal neovascularisation in a paediatric population, Published online: 2018-03-20; | doi:10.1038/s41433-018-0074-7)

Mar 20
2018

Torpedo maculopathy: disease spectrum and associated choroidal neovascularisation in a paediatric population Torpedo maculopathy: disease spectrum and associated choroidal neovascularisation in a paediatric population, Published online: 20 March 2018; doi:10.1038/s41433-018-0074-7 Torpedo maculopathy: disease spectrum and associated choroidal neovascularisation in a paediatric population

  • 20 March 2018

The WCSM Education Trust

Mar 20
2018

The WCSM Education Trust, a charitable organisation founded by The Worshipful Company of Spectacle Makers, has announced a new travel award for ophthalmologists in training who will present their work at a national or international conference in 2018. The Trustees hope that the awards will encourage ophthalmologists who are developing their research whilst training and

  • 20 March 2018

RCOphth recruiting for Curriulcum Subcommittee members to deliver new OST Curriculum

Mar 20
2018

The College is committed to delivering a new Curriculum for Ophthalmic Specialist Training (OST) by 2020 as part of the GMC reform agenda. This represents an opportunity to produce a curriculum that can be delivered in the current NHS climate whilst continuing to drive excellence. We are seeking three new members to join the current Curriculum Sub-committee, to be involved

  • 20 March 2018

BOSU News: No 32. Spring 2018

Mar 20
2018

Welcome to the first BOSU News for 2018. This year marks our coming of age as we enter our 21st year of rare disease surveillance in the UK. In this issue we have summarised the results of our 20-year evaluation. The most noteworthy of which are the high levels of utilisation of study findings and

  • 20 March 2018